September 25, 2019
According to the latest study titled ‘Global Physiological Saline Market Growth 2019-2024’ available with Market Study Report LLC, the global physiological saline market is projected to reach US $3350 million by the year 2024.
Combination of sodium chloride in water results in physiological saline that has several uses in medicines. It is applied in the affected areas to clean wounds, helps with dry eyes and remove contact lenses. It is injected through veins to treat dehydration from diabetic ketoacidosis and gastroenteritis. It also used as a diluting solution for other medication which are to be injected in the body. All these applications will augment the physiological saline market growth in the upcoming years.
As per report, the price of physiological saline is observed to be increasing due to increase in the cost of raw materials. The cost of plastic bottles is quite higher than compared to glass bottles whereas the flexible bag physiological saline is much more expensive than the former two. This factor is presumed to hamper the market growth to some extent, though this impeding factor will be countered and nullified by the varied applications of physiological saline and its increasing demand.
Considering the geographical landscape, the product market is divided into four major regions including Middle East & Africa, Asia Pacific, Americas, and Europe. China dominated the physiological saline market with 33.92% share, owing to its higher population.
The key players operating in physiological saline market profiled in the report comprise of Hospira (Pfizer), Baxter, B. Braun, Fresenius Kabi, Kelun Group, Otsuka, CR Double-Cran, Cisen, SSY Group, Shree Krishna Keshav Laboratories, Pharmally, and Denis Chem Lab Limited.